Evolution Advisers’s ICU Medical ICUI Stock Holding History

Evolution Advisers’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+3	New	+$391	﹤0.01%	522

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Evolution Advisers's ICUI Position: Q2 2026 in Review

Evolution Advisers opened a new position in ICU Medical (ICUI) in Q2 2026: 3 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #522 among its holdings.

287 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

Evolution Advisers held 3 shares of ICU Medical worth $0 as of Q2 2026.
ICU Medical was a new Evolution Advisers position in Q2 2026.
ICU Medical made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #522 holding.
287 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.